{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:06:44Z","timestamp":1773922004532,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 71774075"],"award-info":[{"award-number":["No. 71774075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Center for Health Education and the Anhui Provincial Natural Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-025-01103-8","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T03:47:33Z","timestamp":1765252053000},"page":"163-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of the simplified multicomponent primary care management of cardiovascular risk in Tibet, China: a within-trial and modeled economic evaluation"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8668-1358","authenticated-orcid":false,"given":"Lidan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5660-8571","authenticated-orcid":false,"given":"Maoyi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5454-9627","authenticated-orcid":false,"given":"Nicholas","family":"Peoples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danzeng","family":"Dunzhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-0462","authenticated-orcid":false,"given":"Lijing L.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3044-170X","authenticated-orcid":false,"given":"Lei","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"1103_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12962-018-0108-9","volume":"16","author":"LN Aminde","year":"2018","unstructured":"Aminde LN, Takah NF, Zapata-Diomedi B, Veerman JL. Primary and secondary prevention interventions for cardiovascular disease in low-income and middle-income countries: a systematic review of economic evaluations. Cost Eff Resour Alloc. 2018;16:22.","journal-title":"Cost Eff Resour Alloc"},{"key":"1103_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-2538-z","volume":"15","author":"ED Brouwer","year":"2015","unstructured":"Brouwer ED, Watkins D, Olson Z, Goett J, Nugent R, Levin C. Provider costs for prevention and treatment of cardiovascular and related conditions in low- and middle-income countries: a systematic review. BMC Public Health. 2015;15:1183.","journal-title":"BMC Public Health"},{"key":"1103_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5806-x","volume":"18","author":"A Gheorghe","year":"2018","unstructured":"Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P. The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018;18:975.","journal-title":"BMC Public Health"},{"key":"1103_CR4","first-page":"833","volume":"35","author":"Center For Cardiovascular Diseases The Writing Committee of The Report On Cardiovascular Health And Diseases In China","year":"2020","unstructured":"Center For Cardiovascular Diseases The Writing Committee of The Report On Cardiovascular Health And Diseases In China. Report on cardiovascular health and diseases in China 2019: an updated summary. Biomed Env Sci. 2020;35:833\u201350.","journal-title":"Biomed Env Sci"},{"key":"1103_CR5","first-page":"251","volume":"25","author":"SS Hu","year":"2012","unstructured":"Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, et al. Outline of the report on cardiovascular disease in China, 2010. Biomed Env Sci. 2012;25:251\u20136.","journal-title":"Biomed Env Sci"},{"key":"1103_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","volume":"4","author":"SW Liu","year":"2019","unstructured":"Liu SW, Li YC, Zeng XY, Wang HD, Yin P, Wang LJ, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global burden of disease study. JAMA Cardiology. 2019;4:342\u201352.","journal-title":"JAMA Cardiology"},{"key":"1103_CR7","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1097\/CM9.0000000000002927","volume":"136","author":"ZW Wang","year":"2023","unstructured":"Wang ZW, Ma LY, Liu MB, Fan J, Hu SS. Summary of the 2022 report on cardiovascular health and diseases in China. Chin Med J. 2023;136:2899\u2013908.","journal-title":"Chin Med J"},{"key":"1103_CR8","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.amepre.2017.05.008","volume":"53","author":"D Zhang","year":"2017","unstructured":"Zhang D, Wang G, Joo H. A systematic review of economic evidence on community hypertension interventions. Am J Prev Med. 2017;53:S121\u2013S30.","journal-title":"Am J Prev Med"},{"key":"1103_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s11886-023-01899-2","volume":"25","author":"S Iqbal","year":"2023","unstructured":"Iqbal S, Ali NF, Ladak LA, Shivji R, Zulfiqar M, Barolia R. The scope of practice for primary cardiovascular disease prevention expanded to advanced practice providers: what does the data show? Curr Cardiol Rep. 2023;25:735\u201346.","journal-title":"Curr Cardiol Rep"},{"key":"1103_CR10","doi-asserted-by":"publisher","first-page":"e14275","DOI":"10.2196\/14275","volume":"7","author":"W Sahr","year":"2019","unstructured":"Sahr W, Neesha H, Heather R, Joseph C. Investigating the use of mobile health interventions in vulnerable populations for cardiovascular disease management: scoping review. JMIR Mhealth Uhealth. 2019;7:e14275.","journal-title":"JMIR Mhealth Uhealth"},{"key":"1103_CR11","doi-asserted-by":"publisher","first-page":"e1003582","DOI":"10.1371\/journal.pmed.1003582","volume":"18","author":"LL Yan","year":"2021","unstructured":"Yan LL, Gong E, Gu W, Turner EL, Gallis JA, Zhou Y, et al. Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): a cluster-randomized controlled trial. PLoS Med. 2021;18:e1003582.","journal-title":"PLoS Med"},{"key":"1103_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.mayocp.2014.12.026","volume":"90","author":"RJ Widmer","year":"2015","unstructured":"Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A. Digital health interventions for the prevention of cardiovascular disease: a systematic review and meta-analysis. Mayo Clin Proc. 2015;90:469\u201380.","journal-title":"Mayo Clin Proc"},{"key":"1103_CR13","doi-asserted-by":"publisher","first-page":"e13166","DOI":"10.2196\/13166","volume":"21","author":"X Jiang","year":"2019","unstructured":"Jiang X, Ming WK, You JH. The cost-effectiveness of digital health interventions on the management of cardiovascular diseases: systematic review. J Med Internet Res. 2019;21:e13166.","journal-title":"J Med Internet Res"},{"key":"1103_CR14","doi-asserted-by":"publisher","first-page":"1145562","DOI":"10.3389\/fneur.2023.1145562","volume":"14","author":"E Gong","year":"2023","unstructured":"Gong E, Yang B, Chen X, Li Y, Li Z, Bettger JP, et al. An economic evaluation of a primary care-based technology-enabled intervention for stroke secondary prevention and management in rural China: a study protocol. Front Neurol. 2023;14:1145562.","journal-title":"Front Neurol"},{"key":"1103_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.115.015373","volume":"132","author":"M Tian","year":"2015","unstructured":"Tian M, Ajay VS, Dunzhu D, Hameed SS, Li X, Liu Z, et al. A cluster-randomized, controlled trial of a simplified multicomponent management program for individuals at high cardiovascular risk (SimCard Trial) in rural tibet, China, and Haryana, India. Circulation. 2015;132:815\u201324.","journal-title":"Circulation"},{"key":"1103_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-924","volume":"14","author":"VS Ajay","year":"2014","unstructured":"Ajay VS, Tian M, Chen H, Wu Y, Li X, Dunzhu D, et al. A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale. BMC Public Health. 2014;14:924.","journal-title":"BMC Public Health"},{"key":"1103_CR17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/CM9.0000000000000762","volume":"133","author":"XY Li","year":"2020","unstructured":"Li XY, Shi ZW, Zhao D, Yin DW. 2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease. Chin Med J. 2020;133:1221\u20133.","journal-title":"Chin Med J"},{"key":"1103_CR18","first-page":"12","volume":"2","author":"Cardiovascular Internal Medicine Branch of Chinese Medical Association, Editorial Board of Chinese Journal of Internal Medicine","year":"2010","unstructured":"Cardiovascular Internal Medicine Branch of Chinese Medical Association, Editorial Board of Chinese Journal of Internal Medicine. Consensus of Chinese experts on primary prevention of cardiovascular diseases. Chin J Intern Med. 2010;2:12.","journal-title":"Chin J Intern Med"},{"key":"1103_CR19","unstructured":"National Health Commission of the People\u2019s Republic of China. China health statistics Yearbook 2014. Beijing: Peking Union Medical College Press, 2015."},{"key":"1103_CR20","unstructured":"National Health Commission of the People\u2019s Republic of China. China Health Statistics Yearbook 2018. Beijing: Peking Union Medical College Press, 2018."},{"key":"1103_CR21","unstructured":"Organization for Economic Co-operation and Development (OECD). Consumer price index (all items) for China. 2020. https:\/\/www.oecd.org\/en\/countries\/china-people-s-republic-of.html."},{"key":"1103_CR22","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s11136-017-1614-5","volume":"26","author":"L Si","year":"2017","unstructured":"Si L, Shi L, Chen MS, Palmer AJ. Establishing benchmark EQ-5D-3L population health state utilities and identifying their correlates in Gansu Province, China. Qual Life Res. 2017;26:3049\u201358.","journal-title":"Qual Life Res"},{"key":"1103_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.3390\/ijerph16101721","volume":"16","author":"Q Yao","year":"2019","unstructured":"Yao Q, Liu C, Zhang Y, Xu L. Health-related quality of life of people with self-reported hypertension: a national cross-sectional survey in China. Int J Env Res Public Health. 2019;16:1721.","journal-title":"Int J Env Res Public Health"},{"key":"1103_CR24","doi-asserted-by":"publisher","first-page":"e0211493","DOI":"10.1371\/journal.pone.0211493","volume":"14","author":"YS Yeoh","year":"2019","unstructured":"Yeoh YS, Koh GC, Tan CS, Tu TM, Singh R, Chang HM, et al. Health-related quality of life loss associated with first-time stroke. PLoS One. 2019;14:e0211493.","journal-title":"PLoS One"},{"key":"1103_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","volume":"134","author":"X Yang","year":"2016","unstructured":"Yang X, Li J, Hu D, Chen J, Li Y, Huang J, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population. Circulation. 2016;134:1430\u201340.","journal-title":"Circulation"},{"key":"1103_CR26","unstructured":"World Health Organization. Life Tables by country: Chinese 2014, 2019."},{"key":"1103_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamainternmed.2016.0190","volume":"176","author":"S Lewington","year":"2016","unstructured":"Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. 2016;176:524\u201332.","journal-title":"JAMA Intern Med"},{"key":"1103_CR28","unstructured":"National Bureau of Statistics of China. National data. 2020, China Statistics Press, 2017. https:\/\/www.stats.gov.cn\/english\/Statisticaldata\/yearbook\/."},{"key":"1103_CR29","unstructured":"Professional Committee on Pharmacoeconomics of the Chinese Pharmaceutical Society. Expert consensus on pharmacoeconomic evaluation of clinical trial loading (2024 edition). Chinese Medical Journal, 2024;104:3736\u201344."},{"key":"1103_CR30","first-page":"e1359","volume":"7","author":"T Lung","year":"2019","unstructured":"Lung T, Jan S, de Silva HA, Guggilla R, Maulik PK, Naik N, et al. Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial. Lancet. Glob Health. 2019;7:e1359\u2013e66.","journal-title":"Glob Health"},{"key":"1103_CR31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/hr.2012.173","volume":"36","author":"X Wang","year":"2013","unstructured":"Wang X, Li W, Li X, An N, Chen H, Jan S, et al. Effects and cost-effectiveness of a guideline-oriented primary healthcare hypertension management program in Beijing, China: results from a 1-year controlled trial. Hypertens Res. 2013;36:313\u201321.","journal-title":"Hypertens Res"},{"key":"1103_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/2150131912470459","volume":"4","author":"YM Bai","year":"2013","unstructured":"Bai YM, Zhao YF, Wang GJ, Wang HC, Liu KJ, Zhao WH. Cost-effectiveness of a hypertension control intervention in three community health centers in China. J Prim Care Community Health. 2013;4:195\u2013201.","journal-title":"J Prim Care Community Health"},{"key":"1103_CR33","doi-asserted-by":"publisher","first-page":"e1001860","DOI":"10.1371\/journal.pmed.1001860","volume":"12","author":"D Gu","year":"2015","unstructured":"Gu D, He J, Coxson PG, Rasmussen PW, Huang C, Thanataveerat A, et al. The cost-effectiveness of low-cost essential antihypertensive medicines for hypertension control in China: a modelling study. PLoS Med. 2015;12:e1001860.","journal-title":"PLoS Med"},{"key":"1103_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ypmed.2018.02.033","volume":"111","author":"X Xie","year":"2018","unstructured":"Xie X, He T, Kang J, Siscovick DS, Li Y, Pagan JA. Cost-effectiveness analysis of intensive hypertension control in China. Prev Med. 2018;111:110\u20134.","journal-title":"Prev Med"},{"key":"1103_CR35","first-page":"1000","volume":"48","author":"Chinese Society of Cardiology of Chinese Medical Association, Cardiovascular Disease Prevention and Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiovascular Disease Committee of Chinese Association of Gerontology and Geriatrics,","year":"2020","unstructured":"Chinese Society of Cardiology of Chinese Medical Association, Cardiovascular Disease Prevention and Rehabilitation Committee of Chinese Association of Rehabilitation Medicine, Cardiovascular Disease Committee of Chinese Association of Gerontology and Geriatrics,. et al. Chinese guideline on the primary prevention of cardiovascular diseases. Chin J Cardiology. 2020;48:1000\u201338.","journal-title":"Chin J Cardiology"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01103-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01103-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:47:23Z","timestamp":1773906443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01103-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01103-8","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"10 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol received ethical approval from the institutional review boards at Peking University Health Science Center, China, Public Health Foundation of India, and Duke University, USA. Informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}